Search results for Mitofilin antibody

Mitofilin antibody, Genetex, GTX33318

Mitofilin antibody, Covalab, Ref 00029754

Mitofilin antibody, Genetex, GTX115523

Anti-Mitofilin antibody, Abcam, AB229653

Anti-Mitofilin antibody, Abcam, AB264372

Anti-Mitofilin antibody, Abcam, AB93323

Mitofilin Antibody (YA3231), MedChemexpress, HY-P83486

Mitofilin Antibody (YA3231) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to Mitofilin.

Mitofilin antibody, Internal, Genetex, GTX81949

Anti-Mitofilin antibody [EPR8749], Abcam, AB137057

Species reactivity Mouse, Rat: We have preliminary internal testing data to indicate this antibody may not react with these species. Please contact us for more information. Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .

PE Anti-Mitofilin antibody [EPR8749], Abcam, AB306307

This conjugated primary antibody is "made to order" and it is released using a quantitative quality control method that ensures binding affinity and labelling efficiency of the conjugate. Via leveraging the power of the Lightning-Link ® conjugation technology , Abcam will deliver highly consistent recombinant conjugates in <2 weeks, giving you access to an ever growing portfolio of antibody-label combinations. For suitable applications and species reactivity, please refer to the unconjugated version of this clone. How are conjugated primary antibodies validated? This conjugated primary antibody is released using a quantitative quality control method that evaluates binding affinity post-conjugation and efficiency of antibody labeling. For suitable applications and species reactivity, please refer to the unconjugated version of this clone. Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .